Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/30/19 | $21,500,000 | Series A |
Ajax Health | undisclosed |
